Table 3.

Follow-Up Characteristics at 12 Months

Number	30
TEE, n (%)
Minimal residual flow	2 (7)
Device embolization	1 (3)
Thrombus on device	0 (0)
Freedom from left atrial arrhythmias	21 (70)
Redo ablation	4 (13)
Surgical (Mini) Maze and LAA amputation	3 (10)
Coumadin, n (%)	7 (23)
Complications during follow-up, n (%)
Death	0 (0)
Stroke or transient ischemic attack	0 (0)
Major bleeding	3 (10)*
Minor bleeding	0 (0)

All data are presented as mean ± standard deviation, n (%), or median (25th–75th percentiles). TEE indicates transesophageal echocardiography.

^*All patients were still on oral anticoagulation during bleeding.